No significant change in migration capacity was discernible after ADAM10 depletion, indicating that ADAM17 but not ADAM10 depletion alone is sufficient to decrease tumorigenicity and migration potential of RB cells in vivo. Here, ADAM10 is linked to retinoblastoma.